We are live on ! Find out more
VCM

Violich Capital Management Portfolio holdings

AUM $919M
1-Year Est. Return 40.7%
This Fund
S&P 500
This Quarter Est. Return
+8.25%
1 Year Est. Return
+40.7%
3 Year Est. Return
+100.28%
5 Year Est. Return
+135.3%
10 Year Est. Return
+480.06%
AUM
$279M
AUM Growth
+$22.4M
Cap. Flow
+$2.98M
Cap. Flow %
1.07%
Top 10 Hldgs %
49.23%
Holding
111
New
3
Increased
37
Reduced
50
Closed
9

Top Buys

Rank Stock Value
1
AET
Aetna Inc
AET
+$3.8M
2
QCOM icon
Qualcomm
QCOM
+$2.74M
3
DHR icon
Danaher
DHR
+$712K
4
DIS icon
Walt Disney
DIS
+$630K
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$575K

Sector Composition

Rank Sector Weight
1 Technology 34.2%
2 Energy 12.91%
3 Healthcare 12.78%
4 Financials 9.62%
5 Communication Services 8.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAAS icon
101
Pan American Silver
PAAS
$18.2B
-10,520
Closed -$111K
PSX icon
102
Phillips 66
PSX
$84.9B
-4,150
Closed -$240K
TEVA icon
103
Teva Pharmaceuticals
TEVA
$40.8B
-40,341
Closed -$1.52M
VGLT icon
104
Vanguard Long-Term Treasury ETF
VGLT
$10B
-4,600
Closed -$307K
NE
105
DELISTED
Noble Corporation
NE
-9,924
Closed -$328K
IO
106
DELISTED
ION Geophysical Corporation
IO
-667
Closed -$52K
ROSE
107
DELISTED
ROSETTA RESOURCES INC
ROSE
-3,885
Closed -$212K

Similar funds

Violich Capital Management's Q4 2013 Portfolio in Review

As of Q4 2013, Violich Capital Management held 111 positions worth $279M, up 8.7% from $256M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Violich Capital Management's Q4 2013 filing shows 3 new, 37 increased, 50 reduced and 9 closed positions. Its largest new stake was Danaher: 14,477 shares worth $751K. The largest sale was Teva Pharmaceuticals, an estimated $1.52M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 35% a quarter earlier, followed by Energy and Healthcare.

  • Violich Capital Management's largest Q4 2013 buy was Danaher: 14,477 shares worth $751K.
  • Violich Capital Management added most to Aetna Inc in Q4 2013, an estimated $3.8M increase.
  • Violich Capital Management's biggest Q4 2013 reduction was Accenture, cutting an estimated $818K.
  • Violich Capital Management fully exited Teva Pharmaceuticals in Q4 2013, selling an estimated $1.52M.
  • Violich Capital Management's ten largest holdings make up 49% of its $279M portfolio in Q4 2013.
  • Violich Capital Management opened 3 new positions and closed 9 in Q4 2013.
  • Violich Capital Management's portfolio value rose 8.7% quarter-over-quarter to $279M.

Based on Violich Capital Management's 13F filing for Q4 2013, filed 18 Feb 2014.